Roivant Sciences annual revenue
2020
2021
2022
2023
2024
2025
Roivant Sciences Revenue Growth & History (ROIV)
Roivant Sciences reported $8.3M in revenue for fiscal 2025, a decrease of 71.57% from the previous fiscal year.
View full Roivant Sciences company overviewRoivant Sciences annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2026-03-31 | $8.3M | −$20.8M | −71.57% |
| 2024 | 2025-03-31 | $29.1M | −$3.7M | −11.19% |
| 2023 | 2024-03-31 | $32.7M | $1.2M | +3.75% |
| 2022 | 2023-03-31 | $31.5M | −$23.8M | −42.97% |
| 2021 | 2022-03-31 | $55.3M | $31.5M | +132.34% |
| 2020 | 2021-03-31 | $23.8M | — | — |
Roivant Sciences quarterly revenue
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q1 2026 | 2026-06-30 | $1.4M | −$728,000 | −33.55% |
| Q4 2025 | 2026-03-31 | $2.5M | −$5.0M | −66.71% |
| Q3 2025 | 2025-12-31 | $2.0M | −$7.0M | −77.83% |
| Q2 2025 | 2025-09-30 | $1.6M | −$2.9M | −64.89% |
| Q1 2025 | 2025-06-30 | $2.2M | −$5.8M | −72.84% |
| Q4 2024 | 2025-03-31 | $7.6M | $15.7M | +193.22% |
| Q3 2024 | 2024-12-31 | $9.0M | −$6.5M | −42.05% |
| Q2 2024 | 2024-09-30 | $4.5M | $827,000 | +22.67% |
| Q1 2024 | 2024-06-30 | $8.0M | −$13.6M | −63.05% |
| Q4 2023 | 2024-03-31 | −$8.1M | −$5.7M | −242.08% |
| Q3 2023 | 2023-12-31 | $15.6M | −$1.5M | −8.74% |
| Q2 2023 | 2023-09-30 | $3.6M | −$8.9M | −70.89% |
| Q1 2023 | 2023-06-30 | $21.6M | $17.3M | +400.67% |
| Q4 2022 | 2023-03-31 | −$2.4M | −$11.6M | −125.74% |
| Q3 2022 | 2022-12-31 | $17.1M | −$7.3M | −29.95% |
| Q2 2022 | 2022-09-30 | $12.5M | −$1.5M | −10.40% |
| Q1 2022 | 2022-06-30 | $4.3M | −$3.4M | −44.16% |
| Q4 2021 | 2022-03-31 | $9.2M | −$5.9M | −39.11% |
| Q3 2021 | 2021-12-31 | $24.3M | $18.6M | +323.32% |
| Q2 2021 | 2021-09-30 | $14.0M | $12.7M | +957.22% |
| Q1 2021 | 2021-06-30 | $7.7M | $6.2M | +390.80% |
| Q4 2020 | 2021-03-31 | $15.1M | — | — |
| Q3 2020 | 2020-12-31 | $5.8M | — | — |
| Q2 2020 | 2020-09-30 | $1.3M | — | — |
| Q1 2020 | 2020-06-30 | $1.6M | — | — |
Roivant Sciences revenue growth trends
Over the last five reported fiscal years, revenue declined from $23.8M to $8.3M, a compound annual decline of 19.07%. Roivant Sciences's latest reported quarter, Q1 2026, generated $1.4M in revenue, a decrease of 33.55% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Roivant Sciences source filings ↗